Taste umami in chemotherapy with platinum coordination drugs

Not Applicable

• Conditions: Malignant neoplasm of stomach, unspecified; Nutritional deficiency, unspecified; C16.9; E63.9

• Registration Number: RBR-5284zx
• Lead Sponsor: Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto-USP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-05-02
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Study group:
over 18 years of age; undergoing QTX with platinum compounds at the Chemotherapy Center.

Control Group: 18 years; healthy; group formed by the companions of patients.

Exclusion Criteria

Smoking subjects, submitted to radiotherapy, with oral lesions, allergic to the test product (cream cheese and monosodium glutamate)

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The expected outcome is characterized by taste changes;taste alterations are a consequence of the disease and the treatment, which influence the food intake and bring repercussion in the nutritional status of patients submitted to chemotherapy with platinum drugs

Secondary Outcome Measures

Name	Time	Method
The changes could be observed before the onset of the disease, due to the inflammatory process associated with cancer;taste alterations are a consequence of the disease and the treatment, which influence the food intake and bring repercussion in the nutritional status of patients submitted to chemotherapy with platinum derivatives